The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total SMARCA4 assay is a sandwich immunoassay for quantitative detection of total SMARCA4 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total SMARCA4 assay is a sandwich immunoassay for quantitative detection of total SMARCA4 in cellular lysates using Alpha Technology.
Loading...
SMARCA4 (SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily A Member 4), also known as BRG1, is the primary catalytic ATPase subunit of the SWI/SNF (BAF and PBAF) chromatin remodeling complexes and one of the most frequently mutated chromatin regulators in human cancer. SMARCA4 uses the energy of ATP hydrolysis to slide, eject, or restructure nucleosomes, generating chromatin accessibility at enhancers, promoters, and insulators to regulate transcription, DNA repair, and replication. SMARCA4 is essential for the activation of lineage-specific transcriptional programs and cooperates with pioneer transcription factors including FOXA1 and p53 to establish cell identity. SMARCA4 loss-of-function mutations occur in approximately 10% of NSCLC, as well as in ovarian small cell carcinoma of the hypercalcemic type (SCCOHT), SMARCA4-deficient thoracic sarcoma, and various other solid tumors. Loss of SMARCA4 creates a dependency on the paralogous SMARCA2 subunit, establishing the synthetic lethal vulnerability exploited by SMARCA2-targeted therapies. SMARCA4 mutations also sensitize tumors to EZH2 inhibitors due to the opposing roles of SWI/SNF and PRC2 in chromatin regulation, providing additional therapeutic opportunities in SMARCA4-deficient cancers.
The AlphaLISA SureFire Biotin-Free Human and Mouse Total SMARCA4 Detection Kit is a sandwich immunoassay for the quantitative detection of total SMARCA4 in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Biotin Free kits are compatible with:
AlphaLISA SureFire Biotin Free kits can be used for:
The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).
The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.
HeLa and LNCaP cells were seeded in a 96-well plate (40,000 cells/well for HeLa and 60,000 cells/well for LNCaP) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of ACBI1 for 4 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). SMARCA4 and ERK Total levels were evaluated using AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells for HeLa and 6,000 cells for LNCaP) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, ACBI1 (SMARCA2/4 PROTAC) treatment resulted in a decrease of SMARCA4 levels, while ERK levels remained unchanged.
Total SMARCA4 expression levels were assessed in parallel with Total SMARCA2 in a panel of relevant cell lines.
SMARCA2 and SMARCA4 Total levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (4,000 adherent cells and 40,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, SMARCA2 and SMARCA4 expression is dependent upon cell type. SMARCA2 is expressed in A549 cells, whilst SMARCA4 is undetectable. Conversely, SMARCA4 is expressed in Caco-2 cells where SMARCA2 is undetectable.
These results demonstrate the specificity of the SMARCA2 and SMARCA4 assays as these 2 proteins share more than 70% sequence identity.
Adherent cells were seeded in a 96-well plate (40,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Suspension cells were harvested, washed, and seeded in a 96-well plate (400,000 cells/well).
Cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). SMARCA4 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (4,000 adherent cells and 40,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
SMARCA4 is highly expressed in a wide variety of cell lines.
Cell lysate was prepared from SH-SY5Y cells cultured to confluence in a T175 flask and lysed in 8 mL of Lysis Buffer for 10 minutes at RT with shaking.
Lysate was serially diluted in Lysis Buffer and SMARCA4 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The assay can detect SMARCA4 expression in less than 300 cells/datapoint.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Biotin-Free
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
SMARCA4
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
Oncology
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...
Loading...
We are here to answer your questions.